The Global
HPAPI Summit
for Pharma Leaders
Where the world's leading experts in high-potency active pharmaceutical ingredients converge to shape the future of precision medicine.
The Premier HPAPI Conference
in Europe
MaxPotent Pharma Summit is the leading industry event dedicated to the evolving challenges and advances in the field of high-potency active pharmaceutical ingredients (HPAPIs). As the global HPAPI market is expected to reach $46.9 billion by 2030, driven by increasing demand for oncology drugs, antibody drug conjugates (ADCs), and precision medicine, this summit is a key platform for pharmaceutical innovators, regulatory experts, and contract manufacturing organisations (CMOs/CDMOs).
Over the course of two highly specialised days, delegates will delve into the latest regulatory frameworks, containment technologies, process design innovations, and risk mitigation strategies — ensuring that industry stakeholders can navigate compliance, optimise manufacturing, and improve occupational safety in high-potency drug development.
The 2026 edition builds on the strong foundation of our inaugural summit, with an expanded agenda designed to address critical challenges and opportunities across the HPAPI value chain. This year's programme highlights the latest developments in EU and global regulatory frameworks, emerging containment and isolation technologies, and state-of-the-art automation transforming manufacturing practices.
Delegates will gain actionable insights from real-world case studies, panel discussions, and technical presentations covering occupational health and safety standards, scaling-up strategies, risk-based exposure assessments, supply chain resilience, partnership models with CDMOs/CMOs, sustainability in high-potency operations, and the integration of digital tools in pharma manufacturing.
EU Regulatory Frameworks
Adapting to the latest EMA and ECHA requirements to ensure compliance in HPAPI production.
Innovative Containment Technologies
Designing next-generation facilities with advanced isolators and fully closed systems.
AI & Machine Learning in Manufacturing
Driving precision manufacturing through real-time analytics and process analytical technologies (PAT).
Sustainability in HPAPI Operations
Reducing environmental impact through waste management and alignment with EU Green Deal goals.
Four reasons to join us in Milan
Stay Ahead of the Science
Access the latest regulatory updates, containment innovations, and manufacturing breakthroughs from world-leading HPAPI researchers and industry veterans.
Strategic Networking
Connect with 300+ senior decision-makers through structured 1:1 sessions, roundtables, and the Day 1 networking drinks reception.
Real-World Case Studies
Learn from live technical case studies and product demonstrations highlighting real applications, challenges, and best practices in high-potent drug manufacturing.
Senior-Level Audience
Engage with a highly curated audience of pharma executives, regulatory authorities, CMO/CDMO leaders, and occupational health specialists from across Europe and beyond.
Built for the entire HPAPI value chain
Pharma & Biotech
R&D Directors, VP Manufacturing, Heads of Regulatory Affairs, CMC Leads
CMOs & CDMOs
Contract manufacturing leaders specialising in HPAPI handling, containment, and scale-up
Regulatory & EHS
EMA/ECHA compliance teams, occupational health scientists, risk assessment specialists
Tech & Equipment
Containment system vendors, isolator manufacturers, automation & PAT technology providers
Who will be in the room
Based on our 2026 inaugural edition. The 2026 edition is expected to match and exceed these benchmarks.
Audience by sector
Seniority breakdown
The industry you operate in
is growing fast
Projected market value driven by oncology, ADCs, and precision medicine demand
One of the fastest-growing segments across the global pharmaceutical industry
High-potency compounds now dominate oncology drug development pipelines globally
Active compounds in clinical and pre-clinical development requiring specialist expertise
Planned CDMO and containment facility investments across Europe over the next 5 years
Reported increase in occupational exposure events underscoring urgency of better containment
Speakers for Milan 2026
Building on the success of the MaxPotent Pharma Summit 2026 — which welcomed keynote presentations from industry leaders including Justin Mason-Home on strategic elements within HPAPI projects — the 2026 edition will feature an expanded faculty of 25+ expert speakers from pharma, biotech, CDMOs, and regulatory bodies. Speakers for May 2026 are currently being confirmed. If you are a recognised expert in HPAPI manufacturing, containment technologies, regulatory compliance, or occupational health, we invite you to apply to speak.
Manufacturing & Containment
Keynotes and technical presentations on next-generation containment systems, facility design, continuous processing, automation, and scale-up strategies for high-potency compounds.
Apply to Speak
Regulatory, Safety & Compliance
Expert sessions on evolving EMA and ECHA frameworks, risk-based exposure assessments, occupational health management, supply chain resilience, and CDMO partnership models.
Apply to SpeakAgenda at a glance
Two intensive days spanning the full HPAPI value chain — from regulatory compliance and containment engineering to automation, sustainability, and supply chain resilience.
Wednesday, 6 May 2026
Thursday, 7 May 2026
Drinks Reception
End of Day 1 from 17:30 — informal, relationship-first networking
1:1 Meetings
Structured matchmaking with sponsors, speakers, and delegates
Networking Lunches
Shared lunches both days — cross-industry connection opportunity
Sponsor Exhibition
Dedicated exhibition space running across both conference days
Trusted by Industry Leaders
Companies who sponsor MaxPotent Pharma Summit to reach a highly concentrated audience of HPAPI decision-makers, technical experts, and contract manufacturing leaders.
Why sponsor MaxPotent 2026
Sponsoring MaxPotent Pharma Summit places your brand at the centre of Europe's most focused HPAPI conference, with direct access to 300+ senior decision-makers you cannot reach anywhere else.
Speaking Access
Reserved branded speaking slot in the main programme (Platinum & Gold) — 30 minutes on Day 1.
Exhibition Space
Dedicated 10×6ft stand for live product demos and direct delegate engagement across both days.
Attendee List
Post-event delegate list with contact details for structured follow-up outreach after the summit.
1:1 Matchmaking
Up to 10 pre-arranged one-to-one meetings with your most relevant delegates and prospects.
Brand Visibility
Logo placement across the website, programme brochure, email campaigns, and all on-site materials.
Social Media Coverage
Pre and post-event coverage across MaxPotent's LinkedIn and email channels to 5,000+ subscribers.
Voices from Milan 2026
Don't take our word for it. Here's what professionals who attended the inaugural MaxPotent Pharma Summit said about their experience.
"The event was exceptionally well organised, offering ample networking opportunities. The topics shared by the speakers were both interesting and highly relevant. We look forward to collaborating with Convolign on future events."
"We truly felt we were at the right place. Over the past two days, we had insightful discussions around containment systems. We will definitely look forward to joining next year's edition."
"The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition."
"My experience here at MaxPotent 2026 has been really great. Networking sessions were excellent and we consider MaxPotent a strategic conference for the coming years."
"Quality of the talks was really nice and the attendee list had experts from the biotech and pharma field. It was great meeting everyone and we look forward to positive outcomes."
"It was a very good experience with excellent attendee participation. The topics covered were highly relevant and interesting. We are definitely looking forward to joining the event in 2026."
Glimpses of Milan 2026
Our 2026 inaugural edition brought together 300+ senior professionals at Duo Milan Porta Nuova for two days of scientific exchange and strategic networking.
Opening Keynote
Justin Mason-Home on strategic HPAPI project elements
Panel Discussion
Containment systems & occupational safety roundtable
Networking Reception
End-of-day drinks at Duo Milan Porta Nuova
Sponsor Exhibition
Live product demonstrations across both days
Join us in Milan
Ramada Plaza by Wyndham Milano
Milan, Italy — A premier business hotel in the heart of one of Europe's leading pharmaceutical hubs. Full venue and accommodation details shared with registered delegates and confirmed sponsors.
Get in touch
with our team
For registration enquiries, speaking opportunities, or sponsorship packages, our team is ready to assist.